4 Oct 2013 14:38
For immediate release | 4 October 2013 |
ABCAM PLC
("Abcam" or "the Company")
Director's dealings
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of protein research tools, was notified on 4 October 2013 that, on 3 October 2013, a trust, of which Jonathan Milner, a Director of the Company, is a trustee, has sold 100,000 ordinary shares of 0.2p each in the Company at a price of 500.5 pence per share. Following this transaction, Dr Milner's total interest in the Company is 26,597,385 ordinary shares of 0.2p each representing approximately 13.3% of the Company's issued share capital, which is constituted as follows:
Beneficial Interest (remains unchanged) |
26,494,885 |
Non-Beneficial Interest: | 102,500 |
For further information please contact:
Abcam | + 44 (0) 1223 696 000 |
Jeff Iliffe, Chief Financial Officer
| |
Numis Securities - Nominated Adviser & Joint Broker | + 44 (0) 20 7260 1000 |
Michael Meade - Nominated Adviser | |
James Black - Corporate Broking
| |
Peel Hunt LLP - Joint Broker | + 44 (0) 20 7418 8900 |
Andy Crossley - Corporate Broking
| |
Buchanan | + 44 (0) 20 7466 5000 |
Mark Court / Fiona Henson / Sophie Cowles |
Notes for editors:
About Abcam plc
Abcam plc is a leading provider of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse cells at the molecular level to improve the understanding of health and disease.
Abcam is committed to providing scientists with access to the correct reagents and tools for their research. The Company's catalogue currently comprises more than 124,500 products and is continually evolving to meet customer needs. The range offered includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam products are supported with detailed, up-to-date and unbiased data on our website.
Headquartered in Cambridge, UK, Abcam has eight global subsidiary offices and ships to over 100 countries. The Company was founded in 1998, and now employs over 700 people. Abcam is quoted on the AIM market of the London Stock Exchange (AIM: ABC).
To find out more, please visit www.abcam.com